
PRISM
206A.TPRISM BioLab Co.,LTD Price (206A.T)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
31,354,800
(13.5979)%Income Statement Summary
Revenue | |
Cost of Revenue | |
Gross Profit | |
Operating Expenses | |
Operating Income | |
Other Expenses | |
Net Income |


Income Statement
PRISM BioLab Co.,LTDCurrency: JPY
YEAR | 2022 | 2023 | 2024 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||
Revenue |
554.40M
+0% |
112.93M
-80% |
305.62M
+171% |
||||||||||||||||
Cost of Revenue | |||||||||||||||||||
Cost of Revenue | 19.26M | 32.62M | 145.08M | ||||||||||||||||
Gross Profit | |||||||||||||||||||
Gross Profit |
535.14M
+0% |
80.31M
-85% |
160.54M
+100% |
||||||||||||||||
Gross Profit Ratio | (0.97%) | (0.71%) | (0.53%) | ||||||||||||||||
Operating Expenses | |||||||||||||||||||
Research and Development | 0.00 | 338.73M | 0.00 | ||||||||||||||||
General and Administrative | 0.00 | 0.00 | 0.00 | ||||||||||||||||
Selling, General & Admin... | 0.00 | 238.08M | 0.00 | ||||||||||||||||
Selling & Marketing Exp... | 0.00 | 0.00 | 0.00 | ||||||||||||||||
Depreciation and Amortiz... | 1.21M | 8.74M | 0.00 | ||||||||||||||||
Other Expenses | -1,496,000.00 | 0.00 | 942.93M | ||||||||||||||||
Total Operating Expenses | 468.45M | 577.17M | 942.93M | ||||||||||||||||
Cost and Exponses | 487.71M | 609.79M | 1.09B | ||||||||||||||||
Operating Income | |||||||||||||||||||
Operating Income |
66.68M
+0% |
-496,868,000.00
-845% |
-782,392,000.00
+57% |
||||||||||||||||
Operating Income Ratio | (0.12%) | (-4.40%) | (-2.56%) | ||||||||||||||||
Other Income and Exp... | |||||||||||||||||||
Interest Income | 21.00k | 19.00k | 356.00k | ||||||||||||||||
Interest Expenses | 0.00 | 0.00 | 13.50M | ||||||||||||||||
Total Other Income/Exp... | 7.48M | -28,836,000.00 | -265,811,000.00 | ||||||||||||||||
EBITDA | |||||||||||||||||||
EBITDA | 67.89M | -488,132,000.00 | -782,392,000.00 | ||||||||||||||||
EBITDA ratio | (0.13%) | (-4.32%) | (-2.56%) | ||||||||||||||||
Income Before Tax | |||||||||||||||||||
Income Before Tax | 74.16M | -525,704,000.00 | -1,048,203,000.00 | ||||||||||||||||
Income Before Tax Ratio | (0.13%) | (-4.66%) | (-3.43%) | ||||||||||||||||
Income Tax Expense | |||||||||||||||||||
Income Tax Expense | 1.19M | 1.21M | 1.31M | ||||||||||||||||
Net Income | |||||||||||||||||||
Net Income | 72.96M
+0% |
-526,914,000.00
-822% |
-1,049,514,000.00
+99% |
||||||||||||||||
Net Income Ratio | (0.13%) | (-4.67%) | (-3.43%) | ||||||||||||||||
Earning Per Share | |||||||||||||||||||
Basic EPS | 0.00 | -14.90 | -33.47 | ||||||||||||||||
Diluted EPS | 0.00 | -19.09 | -33.47 | ||||||||||||||||
Share Outstanding | |||||||||||||||||||
Basic Share Outstanding | 0.00 | 35.35M | 31.35M | ||||||||||||||||
Diluted Share Outstanding | 0.00 | 27.60M | 31.35M |